Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function
Nonclinical
Chemical
Analysis
Clapp (2017)
Cinnamaldehyde in flavored e-cigarette liquids temporarily suppresses bronchial epithelial cell ciliary motility by dysregulation of mitochondrial function
Nonclinical
Respiratory Toxicity
Clapp (2019)
Profiles of Nicotine and Cannabis Exposure among Young adults with asthma.
Individual Clinical
User Topography
Clawson (2022)
Symptoms of Depression and Anxiety and Subsequent Use of Nicotine and THC in Electronic Cigarettes.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Clendennen (2023)
Youth vaping beliefs and behaviors: evidence from New York.
Population Clinical
Consumer Use
Youth Use & Appeal
Coats (2022)
Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Cobb (2019)
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Individual Clinical
Pharmacokinetics & Abuse Liability; Safety
Adverse Effects
Cobb (2021)
Using e-cigarettes for smoking cessation: evaluation of a pilot project in the North West of England.
Population Clinical
Cessation
Tobacco
Coffey (2020)
Changes in Biomarkers of Cigarette Smoke Exposure after 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: a Randomized Controlled Confinement Study in adult Smokers.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Cohen (2021)
Combinations of electronic nicotine delivery system device and liquid characteristics among U.S. adults.
Individual Clinical
User Topography
Cohen (2022)